PSM and difference-in-difference estimation
| Panel A: Probit regression to match hedge fund activism firms with control firms | |
|---|---|
| (1) | |
| Probit (hedge fund intervention) | |
| ROA t−1 | −0.328 (−1.565) |
| Leverage t−1 | −0.222 (−1.172) |
| Sizet−1 | −0.100*** (−2.644) |
| Tobin Q t−1 | −0.055* (−1.682) |
| Sales growth t−1 | −0.000 (−0.011) |
| Payout yield t−1 | −0.020 (−0.018) |
| R&D t−1 | −0.264 (−0.710) |
| Institution t−1 | 0.697*** (4.319) |
| Analyst following t−1 | −0.006 (−0.691) |
| Segment HHI t−1 | −0.014 (−0.050) |
| Tangibility ratio t−1 | 0.200** (2.037) |
| Constant | −1.790*** (−8.037) |
| Adjusted R2 | 0.033 |
| Industry- and year-fixed effects | Yes |
| Observations | 20,060 |
| Note(s): This panel reports the results of a probit regression used to estimate the propensity that a firm will be targeted by an activist hedge fund. The model and control variables are comparable to those used by Brav et al. (2008a, b), where various covariants explaining the propensity of hedge fund activist interventions are determined. We use these results to match targeted firms to non-targeted firms by utilizing an estimated PSM procedure | |
| Panel A: Probit regression to match hedge fund activism firms with control firms | |
|---|---|
| (1) | |
| Probit (hedge fund intervention) | |
| ROA | −0.328 (−1.565) |
| Leverage | −0.222 (−1.172) |
| Size | −0.100*** (−2.644) |
| Tobin | −0.055* (−1.682) |
| Sales growth | −0.000 (−0.011) |
| Payout yield | −0.020 (−0.018) |
| R&D | −0.264 (−0.710) |
| Institution | 0.697*** (4.319) |
| Analyst following | −0.006 (−0.691) |
| Segment HHI | −0.014 (−0.050) |
| Tangibility ratio | 0.200** (2.037) |
| Constant | −1.790*** (−8.037) |
| Adjusted | 0.033 |
| Industry- and year-fixed effects | Yes |
| Observations | 20,060 |
| Panel B: Differences in firm fundamentals between treatment and control firms | ||||
|---|---|---|---|---|
| Variable | Treatment | Control | Difference | T value |
| ROA t−1 | −0.002 | 0.018 | −0.020 | −0.870 |
| Leverage t−1 | 0.167 | 0.168 | −0.002 | −0.060 |
| Sizet+1 | 5.988 | 6.316 | −0.329 | −1.740* |
| Tobin Q t−1 | 1.629 | 1.786 | −0.157 | −1.120 |
| Sales growth t−1 | 0.240 | 0.068 | 0.172 | 1.030 |
| Payout yield t−1 | 0.012 | 0.007 | 0.005 | 1.540 |
| R&D t−1 | 0.064 | 0.067 | −0.003 | −0.240 |
| Institution t−1 | 0.713 | 0.745 | −0.032 | −1.020 |
| Analyst following t−1 | 6.276 | 7.158 | −0.882 | −1.180 |
| Segment HHI t−1 | 0.337 | 0.379 | −0.042 | −1.630 |
| Tangibility ratio t−1 | 0.514 | 0.434 | 0.080 | 1.790* |
Note(s): Panel B tabulates the differences in characteristics between firms that are targeted by hedge fund activists (treatment firms) and nontargeted firms (control firms) that are matched using propensity scores based on the Probit model in Panel A. For each treatment firm year, we find three matched control firms | ||||
| Panel B: Differences in firm fundamentals between treatment and control firms | ||||
|---|---|---|---|---|
| Variable | Treatment | Control | Difference | |
| ROA | −0.002 | 0.018 | −0.020 | −0.870 |
| Leverage | 0.167 | 0.168 | −0.002 | −0.060 |
| Size | 5.988 | 6.316 | −0.329 | −1.740* |
| Tobin | 1.629 | 1.786 | −0.157 | −1.120 |
| Sales growth | 0.240 | 0.068 | 0.172 | 1.030 |
| Payout yield | 0.012 | 0.007 | 0.005 | 1.540 |
| R&D | 0.064 | 0.067 | −0.003 | −0.240 |
| Institution | 0.713 | 0.745 | −0.032 | −1.020 |
| Analyst following | 6.276 | 7.158 | −0.882 | −1.180 |
| Segment HHI | 0.337 | 0.379 | −0.042 | −1.630 |
| Tangibility ratio | 0.514 | 0.434 | 0.080 | 1.790* |
| Panel C: Differences in changes in internal control weaknesses between targeted and control firms | ||||
|---|---|---|---|---|
| Variable | Treatment | Control | Difference | T value |
| Change ICWt−1,t+1 | 0.034 | −0.045 | 0.079 | 2.280** |
| Change ICWt+1,t+4 | −0.054 | 0.011 | −0.065 | −3.050*** |
| Panel C: Differences in changes in internal control weaknesses between targeted and control firms | ||||
|---|---|---|---|---|
| Variable | Treatment | Control | Difference | |
| Change ICW | 0.034 | −0.045 | 0.079 | 2.280** |
| Change ICW | −0.054 | 0.011 | −0.065 | −3.050*** |
Note(s): Panel C tabulates the differences in reported internal control weaknesses between firms that are targeted by hedge fund activists (treatment firms) and nontargeted firms (control firms) that are matched using propensity scores based on the Probit model in Panel A. For each treatment firm year, we find three matched control firms. The variables under comparison are the change in internal control weaknesses from t−1 to t+1 and change from t+1 to t+4, where t is the year of the activism event
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Please sign in to your personal account to gift article access.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses.
You have reached the limit of 10 links within a 30 day period.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.